The signal transducer and activator of transcription (STAT) family proteins are transcription factors critical in mediating cytokine signaling. Among them, STAT3 is often constitutively phosphorylated and activated in human cancers and in transformed cell lines and is implicated in tumorigenesis. However, cause of the persistent activation of STAT3 in human tumor cells is largely unknown. The hepatitis C virus (HCV) is a major etiological agent of non-A and non-B hepatitis, and chronic infection by HCV is associated with development of liver cirrhosis and hepatocellular carcinoma. HCV core protein is proposed to be responsible for the virus-induced transformation. We now report that HCV core protein directly interacts with and activates STAT3 through phosphorylation of the critical tyrosine residue. Activation of STAT3 by the HCV core in NIH-3T3 cells resulted in rapid proliferation and up-regulation of Bcl-XL and cyclin-D1. Additional expression of STAT3 in HCV core-expressing cells resulted in anchorage-independent growth and tumorigenesis. We propose that the HCV core protein cooperates with STAT3, which leads to cellular transformation.
Skip Nav Destination
Article navigation
2 September 2002
Article|
September 02 2002
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Takafumi Yoshida,
Takafumi Yoshida
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
2Second Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume 830-0011, Japan
Search for other works by this author on:
Toshikatsu Hanada,
Toshikatsu Hanada
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Search for other works by this author on:
Takeshi Tokuhisa,
Takeshi Tokuhisa
3Department of Developmental Genetics (H2), Graduate School of Medicine, Chiba University, Chuo-ku, Chiba 260-8670, Japan
Search for other works by this author on:
Ken-ichiro Kosai,
Ken-ichiro Kosai
4Department of Medical Science of Regeneration of the Cardiovascular System, Gifu University School of Medicine, Gifu 500-8705, Japan
Search for other works by this author on:
Michio Sata,
Michio Sata
2Second Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume 830-0011, Japan
Search for other works by this author on:
Michinori Kohara,
Michinori Kohara
5Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Honkomagome, Bunkyo-ku, Tokyo 113, Japan
Search for other works by this author on:
Akihiko Yoshimura
Akihiko Yoshimura
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Search for other works by this author on:
Takafumi Yoshida
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
2Second Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume 830-0011, Japan
Toshikatsu Hanada
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Takeshi Tokuhisa
3Department of Developmental Genetics (H2), Graduate School of Medicine, Chiba University, Chuo-ku, Chiba 260-8670, Japan
Ken-ichiro Kosai
4Department of Medical Science of Regeneration of the Cardiovascular System, Gifu University School of Medicine, Gifu 500-8705, Japan
Michio Sata
2Second Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume 830-0011, Japan
Michinori Kohara
5Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Honkomagome, Bunkyo-ku, Tokyo 113, Japan
Akihiko Yoshimura
1Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Address correspondence to Akihiko Yoshimura, Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Phone: 81-92-642-6823; Fax: 81-92-642-6825; E-mail: [email protected]
*
Abbreviations used in this paper: DEN, diethylnitrosamine; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; JAK, Janus kinase; LIF, leukemia-inhibitory factor; MOI, multiplicity of infection; NF, nuclear factor; PCNA, proliferating cell nuclear antigen; STAT, signal transducer and activator of transcription; Tg, transgenic.
Received:
December 24 2001
Revision Received:
June 27 2002
Accepted:
July 17 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (5): 641–653.
Article history
Received:
December 24 2001
Revision Received:
June 27 2002
Accepted:
July 17 2002
Citation
Takafumi Yoshida, Toshikatsu Hanada, Takeshi Tokuhisa, Ken-ichiro Kosai, Michio Sata, Michinori Kohara, Akihiko Yoshimura; Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation . J Exp Med 2 September 2002; 196 (5): 641–653. doi: https://doi.org/10.1084/jem.20012127
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement